-+ 0.00%
-+ 0.00%
-+ 0.00%

HENLIUS REPORTS POSITIVE RESULTS FROM ASTRIDE U.S. BRIDGING STUDY FOR SERPLULIMAB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER (ES-SCLC)

Reuters·10/27/2026 08:22:53

Please log in to view news